Sino Biological Announces Services Partnership with Rapid Novor Mar. 14, 2024 10:32 AM ET Source: Sino Biological
James Satterwhite, CEO of Advanced Glazings, Ltd., to Speak at BuildGreen Atlantic 2024 Conference Mar. 13, 2024 9:00 AM ET Source: Advanced Glazings Ltd.
CEO of Innovative Outcomes, Inc., (OTC:UBQU) Offers Open Letter to Shareholders and Investors Mar. 13, 2024 8:00 AM ET Source: Ubiquitech Software LLC
Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million Mar. 11, 2024 8:15 AM ET Source: Canbiola Inc.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Mar. 6, 2024 9:00 AM ET Source: GeoVax, Inc.
Ubiquitech Software Corp. (OTC:UBQU) Announces Strategic Acquisition of Innovative Outcomes, Inc., an Established Leader in the Multi-Billion Dollar Medical Wound Care Segment Mar. 6, 2024 8:00 AM ET Source: Ubiquitech Software LLC
Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference Mar. 5, 2024 9:00 AM ET Source: Sigyn Therapeutics, Inc.
Review Control (OTC:IMTL) Announces Enhanced API Capabilities Specifically Designed for Unprecedented Impact on the Restaurant and Food Service Sector Mar. 5, 2024 8:00 AM ET Source: Image Protect Inc.
GeoVax Reports 2023 Year-End Financial Results and Provides Business Update Feb. 29, 2024 4:00 PM ET Source: GeoVax, Inc.
Ladybug Resource Group Inc. Announces the Addition of a Chief Financial Officer and New Director Feb. 28, 2024 7:15 AM ET Source: Ladybug Resource Group
TechInvention Lifecare Announces the Ground Breaking of Its State-of-the-Art Global Collaborative Centre for Medical Countermeasures Feb. 27, 2024 11:20 PM ET Source: ACN Newswire
Ubiquitech Software Corp. (OTC: UBQU) Pending Acquisition, Innovative Outcomes, Inc. Creates New Pilot Program to be Introduced to Health Clinics Nationwide Feb. 27, 2024 8:00 AM ET Source: Ubiquitech Software LLC
Review Control (OTC:IMTL) Announces Major Franchise Client Signing and New Product Development Update Feb. 27, 2024 8:00 AM ET Source: Image Protect Inc.
GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024 Feb. 22, 2024 9:00 AM ET Source: GeoVax, Inc.
Sigyn Therapeutics Announces Filing of 2023 Annual Report on SEC Form 10-K Feb. 21, 2024 8:45 AM ET Source: Sigyn Therapeutics, Inc.
AXIM Biotechnologies Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation Feb. 20, 2024 9:00 AM ET Source: AXIM Biotech
GeoVax to Present at the 2024 BIO CEO & Investor Conference Feb. 19, 2024 9:00 AM ET Source: GeoVax, Inc.
Soligenix, Inc. CEO is Featured in an Interview with SmallCaps Daily Jun. 29, 2023 8:07 AM ET Source: Small Caps Daily